Search results for "Salami"
showing 8 items of 28 documents
Preliminary results on the donkey salami made in Sicily
2009
In a dairy jennet farm the meat, which can be produced using the foals in excess, could be another profitable income. Equine meat is very thin and with high protein content; above all, the fatty acids are unsaturated, being a monogastric animal product. The donkey meat processed products are sold in niche market and are very appreciated by the European consumers. A study on the characteristics of the donkey salami made in Sicily was carried out using a 12 months old foal derived from Ragusano breed. Two different mixes were compared: only donkey meat (A thesis) and donkey meat plus the 10% of Nero Siciliano pig fat (AS thesis). The meat was husked of fat and nerves and mixed with 3.5 kg/q o…
The production of typical cured meats from cattle of Cinisara breed
2019
In recent years consumers prefer genuine, tasty, protein-rich, low in fat and cholesterol products. The Cinisara cow is a dairy Sicilian autochthonous breed, reared in the western part of the isle according to the traditional livestock system, based on grazing natural pastures. The meat of Cinisara cattle could be used to obtain also processed products, among which salami and bresaola, as commercial alternatives to fresh meat, in order to increase the economic profitability of farms. The aim of this research was to produce bresaola and salami with meat from adult cows (AC) and grazing (GB) or housed (HB) young bulls of Cinisara breed, evaluating their physico-chemical and sensory traits. In…
« L’héritage de Salamina »
2005
International audience
Minna Salami: Aistien viisaus
2021
Kirja-arvostelu teoksesta Minna Salami, Aistien viisaus, S&S, s.234, suom. Sini Linturi. nonPeerReviewed
Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on topical therapy in ulcerative colitis
2020
Although most patients with ulcerative colitis should be given topical treatment, different studies have shown that they are underused in clinical practice. The purpose of this article is to answer 10 specific questions about which drugs are available for topical use in the treatment of ulcerative colitis, and their characteristics in terms of formulation, dosage, presentation, application and proximal distribution of rectal-administered drugs. The efficacy of available topical drugs and the benefits of combining different formulations and routes of administration, and their usefulness during disease remission are evaluated. Finally, a series of recommendations addressed to patients are giv…
Udział Epifaniusza z Salaminy w walce z kultem obrazów
2017
Epifaniusz, biskup Salaminy na Cyprze w latach 376–403, należał do znaczących postaci w IV w. W działalności publicznej cechowała go radykalna postawa wobec prawd wiary, co bezpośrednio przekładało się na treść jego pism. Obok krytyki wszelkich przejawów heretyckiego myślenia zwalczał ponadto szerzący się wówczas kult obrazów. Taka opinia o nim stała się bardzo głośna dopiero w XX w., gdyż przed 100 laty, czyli w 1916 r., Karl Holl opublikował dosyć obszerne studium, w którym prezentuje tekst trzech utworów Epifaniusza potępiających oddawanie czci obrazom. Adresatami tych pism byli: biskup Jan Jerozolimski, cesarz Teodozjusz oraz członkowie jego wspólnoty kościelnej. Te trzy traktaty Epifan…
Mesalazine for the treatment of inflammatory bowel disease
2013
Ulcerative colitis (UC) and Crohn's disease (CD) represent a chronic inflammatory condition of the bowel that often require lifelong medical therapy for the induction and maintenance of the remission. Mesalazine therapies are available both as oral delayed-release and sustained-release formulation, topical formulations and as prodrug.Available literature regarding mesalazine is extensively reviewed in this article, covering its mechanism of action, pharmaceutics and pharmacokinetics, clinical efficacy, safety and tolerability in different settings.Mesalazine has a well-established role in the management of UC. It is the treatment of choice in active and inactive mild-to-moderate UC combinin…
Is 5-ASA Still the Treatment of Choice for Ulcerative Colitis?
2010
5-Amino-salacylic acid (5-ASA) is up to now the treatment of choice in the induction and maintenance of remission of mild-to-moderate ulcerative colitis (UC). Sulfasalazine, despite similar efficacy, is hampered by more side effects, but in presence of peripheral arthopaties it remains the treatment of choice. The new delayed release MMX formulation seems to be promising in reducing compliance problems, but further studies are warranted to show the superiority of new MMX formulation compared with the older formulations of 5-ASA. Some trials evaluated also the efficacy and safety of once-daily dosing of older 5-ASA formulations in maintenance of remission, finding a greater adherence to ther…